- Home
- LVRO vs AVIR Comparison
LVRO vs AVIR Comparison
Compare LVRO & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- AVIR
- Stock Information
- Founded
- LVRO 2017
- AVIR 2012
- Country
- LVRO Brazil
- AVIR United States
- Employees
- LVRO N/A
- AVIR N/A
- Industry
- LVRO Blank Checks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- LVRO Finance
- AVIR Health Care
- Exchange
- LVRO Nasdaq
- AVIR Nasdaq
- Market Cap
- LVRO 279.6M
- AVIR 273.0M
- IPO Year
- LVRO N/A
- AVIR 2020
- Fundamental
- Price
- LVRO $2.09
- AVIR $3.60
- Analyst Decision
- LVRO Sell
- AVIR Hold
- Analyst Count
- LVRO 3
- AVIR 1
- Target Price
- LVRO $1.88
- AVIR $6.00
- AVG Volume (30 Days)
- LVRO 7.0K
- AVIR 409.3K
- Earning Date
- LVRO 07-11-2025
- AVIR 08-06-2025
- Dividend Yield
- LVRO N/A
- AVIR N/A
- EPS Growth
- LVRO N/A
- AVIR N/A
- EPS
- LVRO N/A
- AVIR N/A
- Revenue
- LVRO $1,667,345,189.00
- AVIR N/A
- Revenue This Year
- LVRO N/A
- AVIR N/A
- Revenue Next Year
- LVRO $12.46
- AVIR N/A
- P/E Ratio
- LVRO N/A
- AVIR N/A
- Revenue Growth
- LVRO N/A
- AVIR N/A
- 52 Week Low
- LVRO $1.90
- AVIR $2.46
- 52 Week High
- LVRO $5.69
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- LVRO 44.09
- AVIR 71.04
- Support Level
- LVRO $1.90
- AVIR $3.43
- Resistance Level
- LVRO $2.28
- AVIR $3.73
- Average True Range (ATR)
- LVRO 0.19
- AVIR 0.13
- MACD
- LVRO -0.03
- AVIR 0.03
- Stochastic Oscillator
- LVRO 32.97
- AVIR 73.04
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).